Skinbiotherap. Share Chat (SBTX)

Think realisation that the study results were truly outstanding is really setting in, couple with a very high possibility that demand will quickly outstrip supply later this year. I'm pleased to be part of a company that's going to bring so much relief to many thousands of people that have been suffering for years.

Unusual only insofar as the recent ( few weeks plus) the progress to 64/64/+ has been lost shortly after close. Perhaps UT though I didn't see anything specific.
And then on Friday the gain, on limited trades, remained.
So, unusual in terms of recent behaviour.
Probably of no consequence. Nevertheless, a recently established pattern has changed.
We shall see.

?

No 3.5% fall immediately after eot.
Might be slightly significant.

Thanks Belgrano for taking the time to answer my question.
Much appreciated.
Best wishes
HM

Winclove will produce the product for SBTX.
SBTX will operate a B2c model with a margin much greater than 50%. I am guessing nearer 70%.

Do not make the mistake of forgetting the game-changing antiaging cosmetic launches with household names in the same period.

Taste is subjective. Most people will not notice a taste. It can be mixed with hot or cold breakfasts or beverages, which will mask the taste. This short interview I did with SA a month ago will help you. https://soundcloud.com/user-957798193-127487236/stuart-ashman-zoom-2805201-1-sequence-1

I have just bought into this with a hope that this may yield some fruitfull gains. In the meantime I have a few questions that I know some of you will be able to answer.
The company will be starting a limited subscription for the new probiotic formulation in Q4 this year. This is great news but has the company got the means to transform itself (or any detailed plans) to be able to produce the product on a production line to satisfy demand and/or grow sales? For those that have tried it what does it taste like?

Price is stable while we await for the income stream to start.
Best rises are those with foundation on good company profits, currently we have a company here that appears to certainly going places, and on paper could generate a hell of a lot of income so current price is on expectation which clearly could be subject to unforeseen circumstances. So clearly higher risk, and now we have a balance while we wait. I do expect to see further rises but especially nearer the time when we actually start to see that income. Might be from Croda first.

Unsure why the price is stable ?
I was expecting a steady rise recently.
the product looks quite good with good potential?
I am in for the long term.
Can anyone shed light please?
Thanks, Best wishes
HM

Hi, am patient and confident holder. Recall seeing a post on here that we would see an update by end of July, yet you say that it’s end august? Have I missed something? Thanks

Merci!

Elric's e-mail address is (put all the following words together)
lemminginvestor
@
yahoo
.com

We should be getting the latest updates from Stuart in under 4 weeks now outlining plans going forward and potential product launches.
Remember the main advertising via the psoriasis forums has not really started yet, however a list has been started of those "expressing an interest". I actually know of 4 genuine people who have their names on that list, and as some time has already elapsed since the end of the study I contacted them later this afternoon after hearing some surprising news to enquire if they still intended to purchase the product.
As a straw poll of just 4, all four stated that they still intend to purchase the product, with one saying as long as the price was reasonable.

Does depend on the date, but if I can make it I'll drive up from southampton with the intention of staying over and enjoying a glass or three of the famous "trooper".

that is great elrico. Im from liverpoool but live in london now. I bought into Skin late last year and it's been my best performing share. And im so excited about the future too. What a great gesture. So unusual. I would love to come, but maybe not this time

Hi Elrico, thanks yes I'm interested. Where can I find your email address? Nick

Peeps,

I have spoken to Stuart today. He has agreed to make himself available for a meeting/presentation with investors. Sadly for the southern district of Great Britain, it will be held in Manchester. However, if it goes well, I am confident Stuart will be happy to arrange a more southerly expedition at a later date.

There is no date set because I need to know how many wonderful people are interested in meeting Stuart and examining the corporate strategy.

I am super excited for the future of SBTX, for sure. This opportunity would be great for investors.

There are no plans to charge any fee for the is. So, please do not think this is an attempt to lighten your broker accounts.

No format has been agreed upon. If the interest is limited, it will probably go ahead informally with a meal and ales rather than a company presentation.

I may even have a guest speaker. Nope, not me. I am not so cruel!

If you are interested, please email me at lemminginvestor**********

The company is certainly doing well with 934M sales and 218M profit. Good company to get into bed with. I'd like to see our product is as much of their products as possible.
Glad to see they want out product to use as a premium ingredient with very beneficial properties.

https://www.lse.co.uk/rns/CRDA/results-for-the-six-months-ended-30-june-2021-zaquv97iqjsd1t9.html

Link here if anyone wants to take a look

To be specific this was an update from Croda International, from my opinion it seems to be doing extremely well which bodes good for us.

Demand from Personal Care customers strengthened during the half year, particularly in luxury and premium markets. This benefitted our Beauty Actives business, the leading innovator in the global skin care market, which increased sales by 26%. Beauty Effects saw a progressive improvement in demand for its ingredients for sun care, cosmetics and hair care markets, growing sales by 11%, but remained constrained by the impact of continued lockdowns in some parts of Asia and Europe. Beauty Formulation had enjoyed resilient sales through pandemic lockdown, with its focus on 'at home' use products, but still delivered 8% growth as lockdowns eased. Innovation is focused on natural ingredients and biotechnology to meet growing consumer demand, with Beauty Actives launching AmeyezingTM, a biodegradable product with its origins in wild ginger that improves the appearance of dark eye circles.

How promising and exciting does this look ? Our products are in a growing market here. Onwards and upwards

SBTX is debt free and has been for the last five years. Also bear in mind that with only seven employees, SBTX has enough cash to cover the company for the next three years. Financially stable, financially sound, and solid fundamentals. We will soon be moving up.

Holding firmly.

One happy investor
Reporting today, Seneca said, despite the unprecedented economic climate and general turmoil of financial markets as a result of the COVID-19 pandemic, the net asset value of its B share increased from 91.8p to 104.6p and the NAV per Ordinary share increased from 30.2p to 39.0p during the period.

The key activities in respect of the B share portfolio in the period included four new investments – three of which were AIM quoted. These involved an increase in the share price of SkinBioTherapeutics from 22p at 31 December 2020 to 63p at 30 June 2021, two partial exits, including a realisation of 1,750,000 in SkinBio shares generating £621,000 and a profit of £341,000, and a dividend of 1.5p per B share paid in May 2021.
https://www.thebusinessdesk.com/northwest/news/2082817-finance-firm-confident-despite-impact-of-coronavirus-pandemic

Tedjames SA is keen for a pharma collab as they would potentially run and finance the full clinical trial required, which I think he said in one of his many interviews would need to be about 4 years long in order to meet all formal requirements. Obviously this means it’s a very long term investment for us to see greater gains (I don’t mind, I’m hooked). The average moderate psoriasis sufferer may have 5 or more different prescriptions to treat each part of the body affected, ( I had 5) including a specific moisturiser, cleansing shampoo, scalp lotion, cream, ointment and foam spray, let alone trying the different ones as some didn’t work effectively. Some prescriptions lasted maybe a month some lasted me 6 months. The pharma potential is huge, this will turn the current steroid treatment market on its head.
This is from an interview last year detailing the routes of each pillar. It’s very interesting listening and a great reassurance of their abilities and potential. Or Skip to 11.22 and 27.35 for the pharma intentions.

https://www.skinbiotherapeutics.com/stuart-ashman-presenting-at-the-share-profits-virtual-show-on-saturday-9th-may-2020/

update by 90 days or aug 20th anyway, creeping closer.